RecruitingPhase 1NCT07103018
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Sponsor: K36 Therapeutics, Inc.
Myrtle Beach, SC · +12 more sites
Clinical trials in Myrtle Beach, SC
35 recruiting studies have a site in or near Myrtle Beach, SC, South Carolina.
Top conditions here
- Prostate Cancer (28)
- Type 2 Diabetes (3)
- Breast Cancer (3)
- Lung Cancer (2)
- Obesity (1)
- Colorectal Cancer (1)
- Rheumatoid Arthritis (1)
- Type 1 Diabetes (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 35 of 35 studies
RecruitingPhase 3NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Sponsor: Amgen
Myrtle Beach, SC · +45 more sites
RecruitingPhase 3NCT07611110
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Sponsor: AstraZeneca
Myrtle Beach, SC · +27 more sites
RecruitingPhase 3NCT07365995
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Sponsor: BioNTech SE
Myrtle Beach, SC · +20 more sites
RecruitingPhase 1NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Sponsor: Pfizer
Myrtle Beach, SC · +43 more sites
RecruitingPhase 3NCT06629779
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Sponsor: Pfizer
Myrtle Beach, SC · +36 more sites
RecruitingPhase 3NCT07028853
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Sponsor: Pfizer
Myrtle Beach, SC · +124 more sites
RecruitingPhase 3NCT07351045
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Sponsor: Hoffmann-La Roche
Myrtle Beach, SC · +43 more sites
RecruitingPhase 2NCT07276581
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Sponsor: AstraZeneca
Myrtle Beach, SC · +28 more sites
RecruitingPhase 3NCT03678025
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Sponsor: SWOG Cancer Research Network
Boiling Springs, SC · Charleston, SC · Greenville, SC · +331 more sites
RecruitingPhase 2NCT07287150
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Hoffmann-La Roche
Myrtle Beach, SC · +5 more sites
RecruitingPhase 3NCT07723248
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
Sponsor: ORIC Pharmaceuticals
Myrtle Beach, SC · +10 more sites
RecruitingPhase 1NCT05176483
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Sponsor: Exelixis
Myrtle Beach, SC · +45 more sites
RecruitingPhase not listedNCT07543757
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
Sponsor: Sequenom, Inc.
Myrtle Beach, SC · +6 more sites
RecruitingPhase 1 / Phase 2NCT06800313
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Sponsor: Janssen Research & Development, LLC
Myrtle Beach, SC · +16 more sites
RecruitingPhase 1NCT06801236
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Acerand Therapeutics (Hong Kong) Limited
Myrtle Beach, SC · +7 more sites
RecruitingPhase 3NCT07164443
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Sponsor: Janssen Research & Development, LLC
Charleston, SC · Greer, SC · Myrtle Beach, SC · +51 more sites
RecruitingPhase 1 / Phase 2NCT07181161
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Myrtle Beach, SC · +10 more sites
RecruitingPhase 3NCT07225946
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Janssen Research & Development, LLC
Myrtle Beach, SC · +58 more sites
RecruitingPhase 3NCT05939414
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Sponsor: Novartis Pharmaceuticals
Myrtle Beach, SC · +38 more sites
RecruitingPhase 2 / Phase 3NCT06780670
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Sponsor: Novartis Pharmaceuticals
Myrtle Beach, SC · +34 more sites
RecruitingPhase 3NCT07392190
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Sponsor: Eli Lilly and Company
Myrtle Beach, SC · +58 more sites
RecruitingPhase 2NCT07332000
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Sponsor: Candel Therapeutics, Inc.
Myrtle Beach, SC · +6 more sites
RecruitingPhase not listedNCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Sponsor: Guardant Health, Inc.
Myrtle Beach, SC · Rock Hill, SC · +31 more sites
RecruitingPhase 3NCT06056830
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Sponsor: Clarity Pharmaceuticals Ltd
Myrtle Beach, SC · +28 more sites
RecruitingPhase 3NCT07662213
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Myrtle Beach, SC · North Charleston, SC · +62 more sites
RecruitingPhase 2NCT07005154
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Sponsor: Astellas Pharma Global Development, Inc.
Myrtle Beach, SC · +11 more sites
RecruitingPhase 3NCT07797335
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Sponsor: Novo Nordisk A/S
Fort Mill, SC · Mt. Pleasant, SC · Myrtle Beach, SC · +106 more sites
RecruitingPhase 2NCT06842498
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Sponsor: Kyntra Bio
Myrtle Beach, SC · +22 more sites
RecruitingPhase 1NCT06257693
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
Sponsor: Alessa Therapeutics Inc.
Myrtle Beach, SC · +9 more sites
RecruitingPhase 1NCT06545942
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Sponsor: MOMA Therapeutics
Myrtle Beach, SC · +11 more sites
RecruitingPhase 3NCT07052214
PSMA PET Combined With MRI for the Detection of PCa
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
Myrtle Beach, SC · +15 more sites
RecruitingPhase 1NCT07244341
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
Sponsor: Daiichi Sankyo
Myrtle Beach, SC · +8 more sites
RecruitingPhase 3NCT04852887
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Sponsor: NRG Oncology
Bluffton, SC · Charleston, SC · Florence, SC · +809 more sites
RecruitingPhase 2NCT06134232
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Sponsor: Dendreon
Charleston, SC · Myrtle Beach, SC · +29 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.